Dr. Branagan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Boston, MA 02114Phone+1 617-726-2000
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2010 - 2012
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 2009 - 2010
Ben Gurion University of the NegevClass of 2009
Certifications & Licensure
CA State Medical License 2024 - 2026
MA State Medical License 2017 - 2026
MD State Medical License 2021 - 2024
NH State Medical License 2024 - 2024
PA State Medical License 2021 - 2024
NC State Medical License 2021 - 2023
ME State Medical License 2020 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients Start of enrollment: 2015 Sep 01
- A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients Start of enrollment: 2021 May 13
- ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy Start of enrollment: 2021 Nov 16
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy.Thomas A Nelson, Naina K Murthy, Maria Martinez-Lage Alvarez, Jeremy Abramson, Andrew R Branagan
Neurology. 2024-11-12 - Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia.Kris Richardson, Jorge J Castillo, Shayna R Sarosiek, Andrew R Branagan, Catherine A Flynn
Blood Advances. 2024-05-14 - 1 citationsCellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies.Mark M Stevens, Robert J Kimmerling, Selim Olcum, Madeleine Vacha, Rachel LaBella
JCO Precision Oncology. 2024-01-01
Press Mentions
Patients with Multiple Myeloma and Waldenström Macroglobulinemia Have Impaired COVID-19 Vaccine ResponsivenessDecember 11th, 2021
Dr. Branagan on Tandem Transplants in Multiple MyelomaMarch 2nd, 2020
More Work Needed to Determine Best Treatment for High-Risk MyelomaFebruary 29th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
